Skip to main content
. Author manuscript; available in PMC: 2021 Sep 25.
Published in final edited form as: Pediatr Res. 2020 Sep 16;90(2):359–365. doi: 10.1038/s41390-020-01162-2

Table 2:

CSO and CMAP from Days 1–14 and Days 1–28 by BPD and WMI Status

No-Mild BPD (n=57) Moderate-to-Severe BPD (n=30) p-value Absent-Mild WMI (n=67) Moderate-Severe WMI (n=8) p-value
CSO 1–14 0.03 (0, 0.3) 0.8 (0.4, 1.5) <0.001 0.20 (0, 0.9) 0.7 (0.3, 0.9) 0.11
CMAP 1–14 31.3 (10.0, 59.7) 125.7 (78.5, 143.7) <0.001 60.8 (19.3, 115.0) 126.4 (64.6, 141.8) 0.04
CSO 1–28 0.06 (0, 0.5) 2.0 (0.7, 3.5) <0.001 0.4 (0.02, 1.8) 2.0 (0.4, 2.6) 0.10
CMAP 1–28 36.3 (10.0, 90.7) 251.7 (153.5, 270.8) <0.001 90.7 (25.7, 235.3) 253.3 (75.3, 262.8) 0.07

Data displayed as median (IQR)

BPD: bronchopulmonary dysplasia; WMI: white matter injury; IQR: interquartile range; CSO: cumulative supplemental oxygen; CMAP: cumulative mean airway pressure